Asia-Pacific markets trade mixed as investors look ahead to U.S. Fed chair Powell’s speech

Asia-Pacific markets trade mixed as investors look ahead to U.S. Fed chair Powell’s speech


SHANGHAI, CHINA – AUGUST 14, 2025 – Tourists are visiting the Bund in Shanghai, China on August 14, 2025.

Cfoto | Future Publishing | Getty Images

Asia-Pacific markets traded mixed Friday as investors await U.S. Federal Reserve Chair Jerome Powell’s speech at the central bank’s annual economic symposium, which could offer clues into the path of interest rates.

South Korea’s Kospi jumped 1.22% and the small-cap Kosdaq was 0.94% higher.

Japan’s benchmark Nikkei 225 slipped 0.1% at the open, while the Topix rose 0.44%.

The country’s core inflation rate cooled to 3.1% in July, coming down from 3.3% the month before. The figure — which strips out costs for fresh food — was higher than the 3% expected by economists polled by Reuters. Rice inflation eased to 90.7% in July, following two months of inflation surging past the 100% mark.

Australia’s benchmark S&P/ASX 200 was flat after the index crossed the 9,000 mark for the first time Thursday.

Mainland China’s CSI 300 was flat at the open, while Hong Kong’s Hang Seng Index rose 0.33%.

Overnight stateside, stocks fell broadly Thursday, with the S&P 500 sliding for the fifth day in a row.

The broad-market index shed 0.4% and closed at 6,370.17, while the Nasdaq Composite slid 0.34% and settled at 21,100.31. The Dow Jones Industrial Average fell 152.81 points, or 0.34%, ending at 44,785.50.

Fed funds futures are pricing in a nearly 74% likelihood of the central bank cutting rates at its next policy gathering in September, according to CME’s FedWatch tool.

— CNBC’s Yun Li and Pia Singh contributed to this report.



Source

Nine of the largest pharma companies ink deals with Trump to lower drug prices
World

Nine of the largest pharma companies ink deals with Trump to lower drug prices

President Donald Trump signs an executive order aimed at reducing the cost of prescription drugs and pharmaceuticals by 30% to 80% during an event in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images Several of the largest U.S. and European-based drugmakers inked deals with […]

Read More
Google’s boomerang year: 20% of AI software engineers hired in 2025 were ex-employees
World

Google’s boomerang year: 20% of AI software engineers hired in 2025 were ex-employees

Sundar Pichai, chief executive officer of Alphabet Inc., during the Bloomberg Tech conference in San Francisco, California, US, on Wednesday, June 4, 2025. David Paul Morris | Bloomberg | Getty Images With the AI talent wars heating up between companies like OpenAI, Meta and Anthropic, one way Google has been competing is by aggressively rehiring […]

Read More
Claire’s new owner Ames Watson feuds with Asia-based suppliers over millions in unpaid debt
World

Claire’s new owner Ames Watson feuds with Asia-based suppliers over millions in unpaid debt

Chris Ratcliffe | Bloomberg | Getty Images Tween retailer Claire’s is facing legal challenges from some of its Asia-based suppliers over millions in unpaid debts as it tries to emerge from a second bankruptcy under new ownership, according to claims the suppliers filed in Hong Kong.  The clash with vendors comes as private equity firm […]

Read More